Glutamatergic augmentation strategies in obsessive-compulsive disorder.

Indian J Psychiatry · 2019 · PMC6343415 · PMID 30745678

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

Only a subset of patients seemed to benefit from riluzole augmentation, which failed to reach statistical significance in the trial.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.